Friday, 13 April 2012 06:45

A Conversation with Chris Calhoun

Written by Daniel Fromson

Cytori Therapeutics probably ranks somewhere near the top of any list of the world's most innovative medical technology companies--or at least a list of its boldest. As CEO Christopher J. Calhoun explains, the company aims to do nothing less than revolutionize health care by leading the way into an era of regenerative medicine, in which damage from cancer, heart disease, and a host of other ailments can be healed with the body's own cells.

The process relies on naturally occurring regenerative cells. "What we have done," Calhoun says, "is developed products that allow a doctor to take a small amount of fat, the same volume as about half a can of Coke

Published in Media "Classics"
Sunday, 23 December 2012 13:27

Jason dines with prominent SC cardiologists


My mailbox has been overflowing off-late with messages of unhappy investors in the Cytori stock. A few days ago, however there was finally a message again with an attachment, that was very positive and worth sharing with the other folks. The report by Jason Kolbert of Maxim´s of his dinner meeting with some leading cardiologists in San Francisco was very interesting. As a fatman, I didnt like his joke very much, but than again- that is of no relevance. Key thing is, that Jason is making great strides in gaining knowledge on the Cell Therapy Industry. Only recently- in August 2012 he displayed his ignorance during the Cytori Conference Call, but has immensely accellerated his knowledge base. Well done Jason- good report- so here you go- just a teaser- if you want to read more of the 26 page report, call Jason at Maxim´s- 212-895-3516.

Published in Media "Classics"
Friday, 20 April 2012 12:48 CYTX Chart widget

The stock price development has been a nightmare for most long term investors, except if one was a trader or short specialist.

The stock has been diluted in a massive way during the past 7 years or so and always at bargain prices when Wallstreet could smell that capital was needed by the Company and choose to drive the PPS down accordingly before financial management of CYTX realized the same and had to dilute near all-time-lows.

Wednesday, 19 September 2012 05:19

Daily Real Time PPS and Volume

If you are not a global investor and trader that uses the tools made available by the probably best (and cheapest) broker- Interactive Brokers- you need some alternatives of course. is an excellent source for data- not only for webmasters, but also for the average investor.















Copyright Information

Copyright Fas Kuiters © 2016 All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.



Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites